Joint Formulary & PAD

HidraWear - Hidradenitis suppurativa

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :

No records returned.

Associated Icons :
BNF SPC
NFD2
Restrictions / Comments :
Important

This product has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making a formulary application.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
HidraWear
Indication :
Hidradenitis suppurativa
Group Name :
Keywords :
Highly exuding wounds, wearable retention dressing systems, absorbent garments
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that HidraWear is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hidradenitis suppurativa.

Committee Recommendations (1)

04 Dec 24 - Not Set

This product has not yet been assessed for formulary status and is not currently on the APC work-plan.

This product has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC).  As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. 

Before prescribing this product it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net  if they wish to make a submission